top of page

Project Timeline

RICOCHET 2 launch

  • In August 2020 RICOCHET 2 is being launched

  • Assessing the 2 year outcomes of the RICOCHET 1 patients

  • Please all sign-up!

Publication of results 

  • Our upcoming manuscript analysing PERT use will soon be ready for dissemination to all authors

  • Our next manuscript will be the pathway results, which is currently being analysed

Study Protocols: About

Data analysis

  • Our statistician is currently working hard analysing over 2500 patient pathways.... watch this space

Data cleaning

  • Our steering committee have completed the mammoth task of cleaning the thousands of REDCap data records

Data upload

  • Data was uploaded by 95 units across the UK. Together they provided us with more than 2800 case records on REDCap. 

Database closure

  • Our REDCap database officially closed in May 2019. No further data could be added or updated after this time. 

Database goes live!

  • Our database (REDCap) went live to uploads in April 2018. 

Pancreatic Cancer UK grant and affiliation

  • In early 2018, we were greatful to receive official recognition and support from Pancreatic Cancer UK!

UK Hospital Recruitment

  • We had more than 110 units sign up to take part in RICOCHET including teams from South Africa, Republic of Ireland and Italy. Unfortunately, RICOCHET is a UK based study only. 

RICOCHET wins a national prize

  • The RICOCHET steering committee were awarded the ASiT/BJS Research Methodology Prize at the 2017 National Research Collaborative Meeting!

Spreading the word

  • Our committee traveled across the UK to collaborative and national scientific meetings to spread the word to HPB surgery and gastroenterology teams about the RICOCHET study. 

MGS Financial Grant

  • We were competatively awarded a monetary grant from the Midlands Gastroenterology Society. 

The Steering Committee

  • Our steering committee have worked tirelessly meeting almost weekly since Autumn 2016 to deliver this daring and important assessment of pancreatic cancer pathways for patients in the UK.

bottom of page